fda semaglutide warning september 2025 Hims & Hers falls 8% as issues letter over compounded weight loss drug fda warning letter hims compounded

Slower transit can also increase reflux or produce delayed sensations when gastric contents finally move into the intestine, further irritating the gastrointestinal tract

The goal is simple: help patients lose weight safely and predictably using treatments backed by science and guided by clinical expertise

Keep semaglutide away from sunlight and heat As you can see, injectable semaglutide has very specific temperature requirements

[8] [18] Lisdexamfetamine, a medication licensed for attention deficit hyperactivity disorder, has shown efficacy in reducing binge eating episodes in some studies, but it is not licensed for BED in the UK and is not routinely recommended due to concerns about dependency and cardiovascular effects